SCHEMBL63843

SCHEMBL63843

[C-]#[N+]C(C1CCC(CO[Si](C)(C)C(C)(C)C)C1)N(C)C(=O)OCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 1/20 0.38
ITGB3 P05106 2/20 0.38
ITGA2B P08514 2/20 0.38
ABCB1 P08183 2/20 0.36
SIGMAR1 Q99720 1/20 0.36
CTSK P43235 3/20 0.34
CTSL P07711 2/20 0.34
CTSB P07858 2/20 0.34
CTSS P25774 2/20 0.34
BTN3A1 O00481 1/20 0.33
CYP3A4 P08684 3/20 0.32
TSHR P16473 1/20 0.32
ATM Q13315 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL63495 0.85 ITGB3 (0.37) PTGIRITGB3ITGA2BABCB1SIGMAR1
SCHEMBL63846 0.83 ITGB3 (0.42) PTGIRITGB3ITGA2BABCB1SIGMAR1
SCHEMBL31045282 0.73 SIGMAR1 (0.51) ABCB1SIGMAR1BTN3A1CYP3A4TSHR
SCHEMBL17352069 0.71 ITGB3 (0.44) ITGB3ITGA2BABCB1SIGMAR1CTSK
SCHEMBL4972692 0.69 ABCB1 (0.38) ITGB3ITGA2BABCB1SIGMAR1CTSK
SCHEMBL25182319 0.68 ABCB1 (0.48) ITGB3ITGA2BABCB1SIGMAR1CTSK
SCHEMBL2633971 0.68
SCHEMBL26688242 0.68 CYP3A4 (0.43) BTN3A1CYP3A4TSHRATMCYP2C9
SCHEMBL26688245 0.68 CYP3A4 (0.43) BTN3A1CYP3A4TSHRATMCYP2C9
SCHEMBL52324 0.68 ITGB3 (0.41) PTGIRITGB3ITGA2BABCB1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129398-B2 HIV integrase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-06 US disclosed
US-20090253677-A1 HIV Integrase Inhibitors BRISTOL-MYERS SQUIBB COMPANY 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253677-A1 HIV Integrase Inhibitors DNTT, POLB, UNG PTGIR 2702/4885ITGB3 2078/4885ITGA2B 1968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.